Použití transdermálního fentanylu v léčbě chronické neonkologické bolesti (výsledky českého a slovenského sledování)

Title in English Transdermal fentanylin the treatment of chronic non-cancer pain (results of the czech and slovak trial)
Authors

ŠEVČÍK Pavel HAKL Marek HŘIB Radovan

Year of publication 2002
Type Article in Periodical
Magazine / Source Bolest
MU Faculty or unit

Faculty of Medicine

Citation
Web http://www.tigis.cz/bolest/Index.htm
Field Surgery incl. transplantology
Keywords transdermal fentanyl; chronic non-cancer; nociceptive; neuropathic pain; constipation
Description Opioids are the mainstay of management of cancer pain. A review of retrospective and prospective data confirms the efficacy of opioids in the treatment of chronic non-cancer pain. The value of opioids in this role has led to the development of management guidelines in various countries. Fentanyl, a lipid soluble synthetic opioid, can be delivered in a transdermal controlled release formulation providing continuous, controlled systemic delivery of fentanyl for up to 72 hours.

You are running an old browser version. We recommend updating your browser to its latest version.

More info